Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q3 2023

Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.

Institution overview
Positions
62
+9 vs. Q2 2023
Portfolio value
$2.58B
+$437.6M (+20.4%) vs. Q2 2023
Filed
Nov 14, 2023
SEC
Holdings of Deep Track Capital, LP in Q3 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
INSMINSMED IncCOM PAR $.016,000,000$151.5M5.9%−500,000−7.7%ReducedHistory
JAZZJazz Pharmaceuticals plcSHS USD1,138,045$147.3M5.7%−111,955−9.0%ReducedHistory
ITCIIntra-Cellular Therapies, Inc.COM2,600,000$135.4M5.3%+1,051,748+67.9%AddedHistory
IONSIonis Pharmaceuticals IncCOM2,834,069$128.6M5.0%00.0%UnchangedHistory
GHGuardant Health, Inc.COM4,050,000$120.0M4.7%+2,550,000+170.0%AddedHistory
IMVTImmunovant, Inc.COM2,797,955$107.4M4.2%−2,623,375−48.4%ReducedHistory
ALKSAlkermes plc.SHS3,800,000$106.4M4.1%+800,000+26.7%AddedHistory
DVAXDynavax Technologies CorpCOM NEW6,756,956$99.8M3.9%+199,140+3.0%AddedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS1,915,000$96.6M3.7%−731,782−27.6%ReducedHistory
PLRXPliant Therapeutics, Inc.COM5,500,000$95.4M3.7%+1,450,000+35.8%AddedHistory
SWTXSpringWorks Therapeutics, Inc.COM3,546,435$82.0M3.2%00.0%UnchangedHistory
AXSMAxsome Therapeutics, Inc.COM1,140,745$79.7M3.1%+756,545+196.9%AddedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS3,490,506$70.1M2.7%+671,461+23.8%AddedHistory
TVTXTravere Therapeutics, Inc.COM7,370,000$65.9M2.6%00.0%UnchangedHistory
NTLAIntellia Therapeutics, Inc.COM2,000,000$63.2M2.5%+1,164,554+139.4%AddedHistory
EDITEditas Medicine, Inc.COM7,101,935$55.4M2.1%+3,648,191+105.6%AddedHistory
GERNGeron CorpCOM25,700,000$54.5M2.1%+1,529,034+6.3%AddedHistory
VRNAVerona Pharma plcSPONSORED ADS3,187,415$52.0M2.0%00.0%UnchangedHistory
APGEApogee Therapeutics, Inc.COM2,414,373$51.4M2.0%+2,414,373NewHistory
PACBPacific Biosciences of California, Inc.COM6,000,000$50.1M1.9%+4,548,799+313.5%AddedHistory
VRDNViridian Therapeutics, Inc.COM2,963,267$45.5M1.8%+1,683,765+131.6%AddedHistory
NVCRNovoCure LtdORD SHS2,500,000$40.4M1.6%+2,500,000NewHistory
HLVXHilleVax, Inc.COM2,900,000$39.0M1.5%+2,900,000NewHistory
RPTXRepare Therapeutics Inc.COM3,067,731$37.1M1.4%+340,125+12.5%AddedHistory
AGENAgenus IncCOM NEW31,697,539$35.8M1.4%+1,697,539+5.7%AddedHistory
FDMT4D Molecular Therapeutics, Inc.COM2,778,107$35.4M1.4%00.0%UnchangedHistory
AUTLAutolus Therapeutics plcSPON ADS15,000,000$35.0M1.4%00.0%UnchangedHistory
NBIXNeurocrine Biosciences IncStock300,000$33.8M1.3%+300,000NewHistory
TERNTerns Pharmaceuticals, Inc.COM6,000,000$30.2M1.2%+4,900,808+445.9%AddedHistory
RAPTRAPT Therapeutics, Inc.COM1,500,000$24.9M1.0%+495,439+49.3%AddedHistory
BEAMBeam Therapeutics Inc.COM1,015,641$24.4M0.9%−301,675−22.9%ReducedHistory
ANABAnaptysbio, IncCOM1,345,813$24.2M0.9%+1,345,813NewHistory
OLMAOlema Pharmaceuticals, Inc.COM1,930,894$23.8M0.9%+1,930,894NewHistory
NRIXNurix Therapeutics, Inc.COM2,997,830$23.6M0.9%00.0%UnchangedHistory
ANIPAni Pharmaceuticals IncCOM400,000$23.2M0.9%−114,021−22.2%ReducedHistory
AMLXAmylyx Pharmaceuticals, Inc.COM1,259,335$23.1M0.9%+1,259,335NewHistory
BNTXBioNTech SESPONSORED ADS200,000$21.7M0.8%+200,000NewHistory
DYNDyne Therapeutics, Inc.COM2,403,672$21.5M0.8%−96,240−3.8%ReducedHistory
MRNAModerna, Inc.Stock200,000$20.7M0.8%+200,000NewHistory
SLNSilence Therapeutics plcADS1,951,580$19.2M0.7%00.0%UnchangedHistory
PNTPOINT Biopharma Global Inc.COM2,781,565$18.6M0.7%00.0%UnchangedHistory
ZURAZura Bio LtdCLASS A ORD SHS2,523,000$16.7M0.6%00.0%UnchangedHistory
ORTXOrchard Therapeutics plcSPON ADS NEW2,041,670$15.8M0.6%+2,041,670NewHistory
EWTXEdgewise Therapeutics, Inc.COM2,750,000$15.8M0.6%00.0%UnchangedHistory
NKTRNektar TherapeuticsCOM18,400,000$11.0M0.4%+426,536+2.4%AddedHistory
MORFMorphic Holding, Inc.COM470,647$10.8M0.4%+253,895+117.1%AddedHistory
AGIOAgios Pharmaceuticals, Inc.COM422,247$10.5M0.4%+422,247NewHistory
ABOSAcumen Pharmaceuticals, Inc.COM2,513,044$10.4M0.4%−1,403,317−35.8%ReducedHistory
NUVBNuvation Bio Inc.COM CL A7,720,688$10.3M0.4%00.0%UnchangedHistory
VIGLVigil Neuroscience, Inc.COM1,767,131$9.52M0.4%−6,278−0.4%ReducedHistory
RLMDRelmada Therapeutics, Inc.COM2,837,818$8.51M0.3%00.0%UnchangedHistory
ATXSAstria Therapeutics, Inc.COM1,037,873$7.74M0.3%−659,542−38.9%ReducedHistory
TXG10x Genomics, Inc.CL A COM182,691$7.54M0.3%+182,691NewHistory
NVAXNovavax IncCOM NEW1,000,000$7.24M0.3%+1,000,000NewHistory
SLRNACELYRIN, Inc.COM551,289$5.61M0.2%+551,289NewHistory
GHRSGH Research PLCORDINARY SHARES499,400$5.02M0.2%00.0%UnchangedHistory
SYRSSyros Pharmaceuticals, Inc.COM NEW828,485$3.27M0.1%+828,485NewHistory
SRRKScholar Rock Holding CorpCOM353,855$2.51M0.1%+353,855NewHistory
CMPSCOMPASS Pathways plcSPONSORED ADS328,424$2.43M0.1%−349,936−51.6%ReducedHistory
HRTXHeron Therapeutics, Inc.COM2,086,704$2.15M0.1%00.0%UnchangedHistory
ETNB89bio, Inc.COM91,078$1.41M0.1%−412,022−81.9%ReducedHistory
IPSCCentury Therapeutics, Inc.COM543,008$1.09M<0.1%−479,884−46.9%ReducedHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q3 2023
SecurityClassPutsCalls
PRTAProthena Corp Public Ltd CoSHS$12.1M–

Sold out since Q2 2023 (7)

Positions held at the end of Q2 2023 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q2 2023
SecurityClassShares in Q2 2023Value in Q2 2023% of portfolio in Q2 2023History
ORTXOrchard Therapeutics plcADS2,041,670$10.6M0.5%History
INZYInozyme Pharma, Inc.COM1,644,021$9.16M0.4%History
ZNTLZentalis Pharmaceuticals, Inc.COM300,300$8.47M0.4%History
MLTXMoonLake ImmunotherapeuticsCLASS A ORD108,450$5.53M0.3%History
ALLKAllakos Inc.COM228,277$995.3K<0.1%History
IMUXImmunic, Inc.COM308,314$773.9K<0.1%History
INKTMiNK Therapeutics, Inc.COM324,867$682.2K<0.1%History